MWNA
SRDX

Marshall Wace North America’s Surmodics SRDX Stock Holding History

Marshall Wace North America’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,481
Closed -$282K – 1763
2020
Q4 		$282K Hold
6,481
– – ﹤0.01% 1180
2020
Q3 		$253K Sell
6,481
-89
-1% -$3.91K ﹤0.01% 1097
2020
Q2 		$284K Hold
6,570
– – ﹤0.01% 1015
2020
Q1 		$218K Buy
6,570
+5,998
+1,049% +$217K ﹤0.01% 888
2019
Q4 		$24K Buy
+572
New +$24.1K ﹤0.01% 1196
2019
Q3 		– Sell
-8,652
Closed -$374K – 1531
2019
Q2 		$374K Buy
+8,652
New +$365K ﹤0.01% 938
2017
Q3 		– Sell
-26,813
Closed -$751K – 1483
2017
Q2 		$751K Buy
+26,813
New +$648K 0.01% 1007

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marshall Wace North America's SRDX Position: Q1 2021 in Review

Marshall Wace North America sold out of Surmodics (SRDX) in Q1 2021, closing a stake of 6,481 shares — an estimated $282K sold.

Marshall Wace North America first reported a position in SRDX in Q2 2017 and held it in 7 quarters. The position peaked at $751K in Q2 2017. 138 funds tracked by Wall St. Rank hold SRDX as of Q1 2021.

  • Marshall Wace North America reported no remaining Surmodics position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 6,481 Surmodics shares in Q1 2021, an estimated $282K.
  • Marshall Wace North America first reported a position in Surmodics in Q2 2017 and held it in 7 quarters.
  • Marshall Wace North America's Surmodics position peaked at $751K in Q2 2017.
  • 138 funds tracked by Wall St. Rank held Surmodics as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.